Tuesday, May 31, 2022

Evotec expands cell therapy manufacturing with acquisition - BioPharma Reporter

One of the additional assets is a gene therapy, known as RR001, which the company had been exploring for the treatment of solid tumors.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...